Skip to main content
OpenTrials

Clinical trial condition

Myopia

Explore clinical trials studying Myopia. Study availability and eligibility vary by location and protocol.

29 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Myopia trial results

Completed

A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

NCT02034006

Conditions
Choroid Diseases, Choroidal Neovascularization, Choroidal Neovascularization Secondary to Pathologic Myopia, +10 more
Locations
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site Bari, BA, Italy
  • Novartis Investigative Site Bologna, BO, Italy
  • Novartis Investigative Site Desenzano del Garda, BS, Italy
View all 31 locations
View Trial Details
Completed

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

NCT01037348

Conditions
Choroid Diseases, Choroidal Neovascularisation, Choroidal Neovascularization, +9 more
Locations
  • Novartis Investigative Site Bristol, United Kingdom
  • Novartis Investigational Site City of London, United Kingdom
  • Novartis Investigative Site City of London, United Kingdom
  • Novartis Investigative Site City of London, United Kingdom
View Trial Details
Completed

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

NCT01217944

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +9 more
Locations
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Linz, Upper Austria, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
  • Novartis Investigative Site Montreal, Quebec, Canada
View all 74 locations
View Trial Details

Related conditions